Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
1.650
0.00 (0.00%)
At close: Mar 28, 2025, 4:00 PM
1.620
-0.030 (-1.82%)
After-hours: Mar 28, 2025, 7:12 PM EDT
Geron Market Cap
Geron has a market cap or net worth of $1.05 billion as of March 28, 2025. Its market cap has increased by 9.97% in one year.
Market Cap
1.05B
Enterprise Value
671.52M
1-Year Change
9.97%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since December 1, 1998, Geron's market cap has increased from $159.40M to $1.05B, an increase of 559.28%. That is a compound annual growth rate of 7.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 1.05B | -50.89% |
| Dec 31, 2024 | 2.14B | 86.74% |
| Dec 29, 2023 | 1.15B | 24.20% |
| Dec 30, 2022 | 922.60M | 134.88% |
| Dec 31, 2021 | 392.80M | -20.44% |
| Dec 31, 2020 | 493.70M | 81.71% |
| Dec 31, 2019 | 271.70M | 45.84% |
| Dec 31, 2018 | 186.30M | -35.00% |
| Dec 29, 2017 | 286.60M | -12.99% |
| Dec 30, 2016 | 329.40M | -56.99% |
| Dec 31, 2015 | 765.80M | 49.89% |
| Dec 31, 2014 | 510.90M | -16.42% |
| Dec 31, 2013 | 611.30M | 231.51% |
| Dec 31, 2012 | 184.40M | -5.24% |
| Dec 30, 2011 | 194.60M | -63.43% |
| Dec 31, 2010 | 532.20M | 4.66% |
| Dec 31, 2009 | 508.50M | 37.54% |
| Dec 31, 2008 | 369.70M | -13.62% |
| Dec 31, 2007 | 428.00M | -26.52% |
| Dec 29, 2006 | 582.50M | 4.37% |
| Dec 30, 2005 | 558.10M | 53.45% |
| Dec 31, 2004 | 363.70M | -6.72% |
| Dec 31, 2003 | 389.90M | 337.60% |
| Dec 31, 2002 | 89.10M | -53.52% |
| Dec 31, 2001 | 191.70M | -42.86% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |